Harmony Biosciences Holdings Inc (HRMY)
29.30
+0.37
(+1.28%)
USD |
NASDAQ |
Apr 26, 16:00
29.30
0.00 (0.00%)
After-Hours: 16:02
Harmony Biosciences Holdings Total Assets (Quarterly): 811.45M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 811.45M |
| September 30, 2023 | 777.77M |
| June 30, 2023 | 760.18M |
| March 31, 2023 | 715.09M |
| December 31, 2022 | 673.87M |
| September 30, 2022 | 643.46M |
| June 30, 2022 | 505.03M |
| March 31, 2022 | 464.00M |
| December 31, 2021 | 433.44M |
| Date | Value |
|---|---|
| September 30, 2021 | 391.09M |
| June 30, 2021 | 359.70M |
| March 31, 2021 | 337.25M |
| December 31, 2020 | 427.07M |
| September 30, 2020 | 320.07M |
| June 30, 2020 | 168.82M |
| March 31, 2020 | 163.09M |
| December 31, 2019 | 106.70M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
106.70M
Minimum
Dec 2019
811.45M
Maximum
Dec 2023
474.01M
Average
433.44M
Median
Dec 2021
Total Assets (Quarterly) Benchmarks
| Amylyx Pharmaceuticals Inc | 517.45M |
| Exelixis Inc | 2.942B |
| Insmed Inc | 1.330B |
| Arcturus Therapeutics Holdings Inc | 429.40M |
| Ultragenyx Pharmaceutical Inc | 1.491B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 344.46M |
| Shareholders Equity (Quarterly) | 466.99M |
| Debt to Equity Ratio | 0.4145 |
| Current Ratio | 2.754 |
| Net Debt Paydown Yield | -0.02% |